Page 71 - BH-2-1

Brain & Heart Mesenchymal cell therapy for heart disease

doi: 10.1093/oxfordjournals.eurheartj.a015434 for ischemic cardiomyopathy: The TAC-HFT randomized
trial. JAMA. 2015;311(1):62-73.
2. Frangogiannis C, Steenbergen N. Chapter 36: Ischemic heart
disease. Hill JA, Olson EN, editors. Muscle. Cambridge: doi: 10.1001/jama.2013.282909
Academic Press; 2012. p. 495-521.
13. Boyle AJ, McNiece IK, Hare JM. Mesenchymal stem
doi: 10.1016/B978-0-12-381510-1.00036-3 cell therapy for cardiac repair. Methods Mol Biol.
2010;660(24):65-84.
3. Han Y, Li X, Zhang Y, Han Y, Chang F, Ding J. Mesenchymal
stem cells for regenerative medicine. Cells. 2019;8(8):886. doi: 10.1007/978-1-60761-705-1_5
doi: 10.3390/cells8080886 14. Butler J, Epstein SE, Greene SJ, et al. Intravenous allogeneic
4. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. mesenchymal stem cells for nonischemic cardiomyopathy:
Heterotopic of bone marrow. Analysis of precursor cells Safety and efficacy results of a Phase II-A randomized trial.
for osteogenic and hematopoietic tissues. Transplantation. Circ Res. 2017;120(2):332-340.
1968;6(2):230-247. doi: 10.1161/CIRCRESAHA.116.309717
5. Guo Y, Yu Y, Hu S, Chen Y, Shen Z. The therapeutic potential 15. Amado LC, Saliaris AP, Schuleri KH, et al. Cardiac repair
of mesenchymal stem cells for cardiovascular diseases. Cell with intramyocardial injection of allogeneic mesenchymal
Death Dis. 2020;11(5):349. stem cells after myocardial infarction. Proc Natl Acad Sci U S
doi: 10.1038/s41419-020-2542-9 A. 2005;102(32):11474-11479.
6. Dominici M, Le Blanc K, Mueller L, et al. Minimal criteria doi: 10.1073/pnas.0504388102
for defining multipotent mesenchymal stromal cells. The 16. Liu CB, Huang H, Sun P, et al. Human umbilical cord‐
international society for cellular therapy position statement. derived mesenchymal stromal cells improve left ventricular
Cytotherapy. 2006;8(4):315-317. function, perfusion, and remodeling in a porcine model
doi: 10.1080/14653240600855905 of chronic myocardial ischemia. Stem Cells Transl Med.
2016;5(8):1004-1013.
7. Jeong H, Yim HW, Park HJ, et al. Mesenchymal stem cell
therapy for ischemic heart disease: Systematic review and doi: 10.5966/sctm.2015-0298
meta-analysis. Int J Stem Cells. 2018;11(1):1-12. 17. Vilahur G, Oñate B, Cubedo J, et al. Allogenic adipose-
doi: 10.15283/ijsc17061 derived stem cell therapy overcomes ischemia-induced
microvessel rarefaction in the myocardium: Systems biology
8. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms study. Stem Cell Res Ther. 2017;8(1):1-15.
in adult stem cell signaling and therapy. Circ Res.
2008;103(11):1204-1219. doi: 10.1186/s13287-017-0509-2
doi: 10.1161/CIRCRESAHA.108.176826 18. Kanelidis AJ, Premer C, Lopez J, Balkan W, Hare JM.
Route of delivery modulates the efficacy of mesenchymal
9. Hatzistergos KE, Quevedo H, Oskouei BN, et al. Bone stem cell therapy for myocardial infarction: A meta-
marrow mesenchymal stem cells stimulate cardiac analysis of preclinical studies and clinical trials. Circ Res.
stem cell proliferation and differentiation. Circ Res. 2017;120(7):1139-1150.
2010;107(7):913-922.
doi: 10.1161/CIRCRESAHA.116.309819
doi: 10.1161/CIRCRESAHA.110.222703
19. Ward MR, Abadeh A, Connelly KA. Concise review: Rational
10. Hare JM, Traverse JH, Henry TD, et al. A randomized, use of mesenchymal stem cells in the treatment of ischemic
double-blind, placebo-controlled, dose-escalation study heart disease. Stem Cells Transl Med. 2018;7(7):543-550.
of intravenous adult human mesenchymal stem cells
(prochymal) after acute myocardial infarction. J Am Coll doi: 10.1002/sctm.17-0210
Cardiol. 2009;54(24):2277-2286. 20. Nakanishi C, Yamagishi M, Yamahara K, et al. Activation
doi: 10.1016/j.jacc.2009.06.055 of cardiac progenitor cells through paracrine effects of
mesenchymal stem cells. Biochem Biophys Res Commun.
11. Hare JM, Fishman JE, Gerstenblith G, et al. Comparison of
allogeneic vs autologous bone marrow-derived mesenchymal 2008;374(1):11-16.
stem cells delivered by transendocardial injection in doi: 10.1016/j.bbrc.2008.06.074
patients with ischemic cardiomyopathy: The POSEIDON 21. Collino F, Deregibus MC, Bruno S, et al. Microvesicles
randomized trial. JAMA. 2012;308(22):2369-2379.
derived from adult human bone marrow and tissue specific
doi: 10.1001/jama.2012.25321 mesenchymal stem cells shuttle selected pattern of miRNAs.
PLoS One. 2010;5(7):e11803.
12. Heldman AW, Difede DL, Fishman JE, et al. Transendocardial
mesenchymal stem cells and mononuclear bone marrow cells doi: 10.1371/journal.pone.0011803

Volume 2 Issue 1 (2024) 5 https://doi.org/10.36922/bh.2065